GODREJCP.NS
Godrej Consumer Products Limited [GODREJCP.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GODREJCP.NS Stock Summary
In the News
GODREJCP.NS Financial details
Company Rating
Neutral
Market Cap
1227.13B
Income
17.85B
Revenue
137.81B
Book val./share
-
Cash/share
-
Dividend
5
Dividend %
0.44%
Employees
13K
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
66.78
Forward P/E
-
PEG
11646.43
P/S
8.51
P/B
8.06
P/C
-
P/FCF
164.13
Quick Ratio
0.69
Current Ratio
1.04
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
17.45
EPS next Y
-
EPS next Q
-
EPS this Y
-4.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-6.18%
Revenue last 5Y
5.06%
Revenue Q/Q
1.53%
EPS Q/Q
34.28%
-
-
-
-
SMA20
-1.8%
SMA50
0.33%
SMA100
20.46%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
25%
ROC
0.18%
Gross Margin
53%
Oper. Margin
19%
Profit Margin
13%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
897.0-1314.3
52W High
-11.05%
52W Low
+30.31%
RSI
42
Rel Volume
0.74
Avg Volume
1.26M
Volume
927.21K
Perf Week
-6.21%
Perf Month
-8.21%
Perf Quarter
21.28%
Perf Half Y
17.22%
-
-
-
-
Beta
0.334
-
-
Volatility
27.79%, 25.5%
Prev Close
0.52%
Price
1168.85
Change
-0.82%
GODREJCP.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 100.91 | 96.95 | 106.96 | 119.06 | 129.07 | |
| Net income per share | 22.91 | 14.64 | 16.83 | 17.44 | 16.65 | |
| Operating cash flow per share | 16.91 | 15.54 | 19.85 | 14.19 | 21.03 | |
| Free cash flow per share | 14.88 | 14.05 | 18.25 | 11.48 | 18.81 | |
| Cash per share | 13.63 | 13.77 | 12.94 | 18.97 | 25.65 | |
| Book value per share | 71.1 | 77.26 | 92.32 | 113.01 | 134.89 | |
| Tangible book value per share | -2.08 | -0.76 | 17.91 | 36.27 | 52.72 | |
| Share holders equity per share | 71.1 | 77.26 | 92.32 | 113.01 | 134.89 | |
| Interest debt per share | 34.7 | 36.54 | 19.17 | 17.38 | 12.76 | |
| Market cap | 691.97B | 532.45B | 746.02B | 764.15B | 990.07B | |
| Enterprise value | 717.17B | 562.17B | 759.42B | 773.68B | 997.78B | |
| P/E ratio | 29.55 | 35.58 | 43.35 | 42.85 | 58.15 | |
| Price to sales ratio | 6.71 | 5.37 | 6.82 | 6.28 | 7.5 | |
| POCF ratio | 40.02 | 33.53 | 36.76 | 52.68 | 46.04 | |
| PFCF ratio | 45.49 | 37.08 | 39.98 | 65.09 | 51.48 | |
| P/B Ratio | 9.52 | 6.74 | 7.9 | 6.61 | 7.18 | |
| PTB ratio | 9.52 | 6.74 | 7.9 | 6.61 | 7.18 | |
| EV to sales | 6.95 | 5.67 | 6.94 | 6.36 | 7.56 | |
| Enterprise value over EBITDA | 33.1 | 26.39 | 32.3 | 31.7 | 38.39 | |
| EV to operating cash flow | 41.48 | 35.4 | 37.42 | 53.34 | 46.39 | |
| EV to free cash flow | 47.15 | 39.15 | 40.7 | 65.9 | 51.88 | |
| Earnings yield | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
| Free cash flow yield | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | |
| Debt to equity | 0.47 | 0.45 | 0.2 | 0.15 | 0.08 | |
| Debt to assets | 0.24 | 0.24 | 0.13 | 0.11 | 0.06 | |
| Net debt to EBITDA | 1.16 | 1.4 | 0.57 | 0.39 | 0.3 | |
| Current ratio | 1.2 | 1.06 | 1.08 | 1.43 | 1.76 | |
| Interest coverage | 12.03 | 12.17 | 23.34 | 31.54 | 13.1 | |
| Income quality | 0.94 | 0.86 | 0.98 | 0.67 | 1.01 | |
| Dividend Yield | 0.02 | 0.02 | 0 | 0 | 0 | |
| Payout ratio | 0.52 | 0.55 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.53 | 0.53 | 0.53 | 0.49 | 0.48 | |
| Capex to operating cash flow | -0.12 | -0.1 | -0.08 | -0.19 | -0.11 | |
| Capex to revenue | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 | |
| Capex to depreciation | -1.22 | -0.77 | -0.8 | -1.32 | -0.96 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 191.43 | 159.53 | 186.98 | 210.59 | 224.78 | |
| ROIC | 0.21 | 0.14 | 0.16 | 0.14 | 0.12 | |
| Return on tangible assets | 0.35 | 0.21 | 0.26 | 0.22 | 0.19 | |
| Graham Net | -34.66 | -34.5 | -15.56 | -6.8 | 6.07 | |
| Working capital | 7.97B | 2.62B | 3.37B | 17.16B | 25.15B | |
| Tangible asset value | -2.12B | -773.9M | 18.31B | 37.08B | 53.91B | |
| Net current asset value | -22.15B | -22.5B | -3.72B | 11.09B | 21.01B | |
| Invested capital | 0.47 | 0.45 | 0.2 | 0.15 | 0.08 | |
| Average receivables | 16.1B | 16.4B | 15.63B | 13B | 12.08B | |
| Average payables | 24.48B | 25.1B | 23.2B | 21.61B | 19.93B | |
| Average inventory | 15.68B | 16.31B | 17.1B | 19.23B | 18.34B | |
| Days sales outstanding | 56.06 | 62.47 | 47.7 | 35.08 | 34.44 | |
| Days payables outstanding | 192.66 | 199.47 | 150.28 | 123.13 | 99.28 | |
| Days of inventory on hand | 118.22 | 136.95 | 119.43 | 121.24 | 83.71 | |
| Receivables turnover | 6.51 | 5.84 | 7.65 | 10.4 | 10.6 | |
| Payables turnover | 1.89 | 1.83 | 2.43 | 2.96 | 3.68 | |
| Inventory turnover | 3.09 | 2.67 | 3.06 | 3.01 | 4.36 | |
| ROE | 0.32 | 0.19 | 0.18 | 0.15 | 0.12 | |
| Capex per share | -2.03 | -1.49 | -1.6 | -2.7 | -2.22 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 34.89 | 31.02 | 33.42 | 34.89 | 35.42 | |
| Net income per share | 5.34 | 4.42 | 3.12 | 4.23 | 5.68 | |
| Operating cash flow per share | 1.12 | 0.2 | 1.49 | 8.49 | 1.05 | |
| Free cash flow per share | 1.12 | 0.2 | 1.49 | 6.76 | 1.05 | |
| Cash per share | 16.34 | 25.64 | 25.06 | 26.1 | 0 | |
| Book value per share | 123.97 | 134.88 | 134.88 | 141.77 | 0 | |
| Tangible book value per share | 0 | 52.71 | 0 | 32 | 0 | |
| Share holders equity per share | 123.97 | 134.88 | 134.88 | 141.77 | 0 | |
| Interest debt per share | 0.39 | 11.56 | 0.72 | 32.77 | 0.65 | |
| Market cap | 893.89B | 990.12B | 1105.54B | 1014.17B | 1170.92B | |
| Enterprise value | 910.6B | 997.84B | 1131.17B | 1041.67B | 1170.92B | |
| P/E ratio | 40.9 | 54.75 | 86.69 | 58.59 | 50.38 | |
| Price to sales ratio | 25.05 | 31.21 | 32.35 | 28.42 | 32.32 | |
| POCF ratio | 779.73 | 4.91K | 724.57 | 116.81 | 1.09K | |
| PFCF ratio | 779.73 | 4.91K | 724.57 | 146.62 | 1.09K | |
| P/B Ratio | 7.05 | 7.18 | 8.01 | 6.99 | 0 | |
| PTB ratio | 7.05 | 7.18 | 8.01 | 6.99 | 0 | |
| EV to sales | 25.52 | 31.46 | 33.1 | 29.19 | 32.32 | |
| Enterprise value over EBITDA | 118.29 | 142.8 | 158.88 | 135.26 | 128.56 | |
| EV to operating cash flow | 794.31 | 4.95K | 741.36 | 119.98 | 1.09K | |
| EV to free cash flow | 794.31 | 4.95K | 741.36 | 150.59 | 1.09K | |
| Earnings yield | 0.01 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0.01 | 0 | |
| Debt to equity | 0 | 0.08 | 0 | 0.23 | 0 | |
| Debt to assets | 0 | 0.06 | 0 | 0.16 | 0 | |
| Net debt to EBITDA | 2.17 | 1.1 | 3.6 | 3.57 | 0 | |
| Current ratio | 0 | 1.76 | 0 | 1.04 | 0 | |
| Interest coverage | 17.85 | 12 | 8.18 | 9.17 | 12.87 | |
| Income quality | 0.21 | 0.04 | 0.48 | 2.01 | 0.19 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0.01 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0.48 | 0 | 0.54 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | -0.2 | 0 | |
| Capex to revenue | 0 | 0 | 0 | -0.05 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | -2.9 | 0 | |
| Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
| Graham number | 122.07 | 115.83 | 97.27 | 116.18 | 0 | |
| ROIC | 0.05 | 0.03 | 0.03 | 0.03 | 0 | |
| Return on tangible assets | 0 | 0.05 | 0 | 0.05 | 0 | |
| Graham Net | 16.34 | 6.07 | 25.06 | -15.97 | 0 | |
| Working capital | 16.71B | 25.15B | 25.63B | 2.59B | 0 | |
| Tangible asset value | 0 | 53.91B | 0 | 32.73B | 0 | |
| Net current asset value | 16.71B | 21.01B | 25.63B | 35M | 0 | |
| Invested capital | 0 | 0.08 | 0 | 0.23 | 0 | |
| Average receivables | 5.47B | 6.23B | 6.23B | 6.79B | 6.79B | |
| Average payables | 10.28B | 9.12B | 9.12B | 9.49B | 9.49B | |
| Average inventory | 9.95B | 7.69B | 7.69B | 7.97B | 7.97B | |
| Days sales outstanding | 0 | 35.33 | 0 | 34.26 | 0 | |
| Days payables outstanding | 0 | 108.86 | 0 | 105.08 | 0 | |
| Days of inventory on hand | 0 | 91.78 | 0 | 88.32 | 0 | |
| Receivables turnover | 0 | 2.55 | 0 | 2.63 | 0 | |
| Payables turnover | 0 | 0.83 | 0 | 0.86 | 0 | |
| Inventory turnover | 0 | 0.98 | 0 | 1.02 | 0 | |
| ROE | 0.04 | 0.03 | 0.02 | 0.03 | 0 | |
| Capex per share | 0 | 0 | 0 | -1.73 | 0 |
GODREJCP.NS Frequently Asked Questions
What is Godrej Consumer Products Limited stock symbol ?
Godrej Consumer Products Limited is a IN stock and trading under the symbol GODREJCP.NS
What is Godrej Consumer Products Limited stock quote today ?
Godrej Consumer Products Limited stock price is $1168.85 today.
Is Godrej Consumer Products Limited stock public?
Yes, Godrej Consumer Products Limited is a publicly traded company.
Company Profile
- Volume Average 1.26M
- Market Capitalization 1227.13B
- Employee 13K
- CEO Mr. Sudhir Sitapati
- Headquarters Mumbai,IN
- IPO Date 2002-07-01
-
Website
https://www.godrejcp.com 
Godrej Consumer Products Limited, a fast-moving consumer goods company, manufactures and markets personal care and home care products in India, Africa, Indonesia, the Middle East, the United States, and internationally. The company offers household insecticides, wet wipes, air fresheners, hair colors, soaps, hair extensions, wet hair, hair relaxers, depilatory products, hair fixing sprays, hair styling products, fabric care, personal wash and hygiene products, and beauty and professional products. It provides its products primarily under the Good knight, Godrej Expert, Cinthol, Godrej No. 1, Hit, Darling, Godrej protekt, Godrej aer, TCB Naturals', MegaGrowth, Just For Me, African Pride Moisture Miracle, Millefiori, Issue, Ilicit, Godrej ProClean, Bidex, Inecto, Stella, Mitu, Saniter, Godrej Ezee, Pamela Grant, Renew, NYU, Roby, 919, and Godrej Professional brands. Godrej Consumer Products Limited was founded in 1897 and is headquartered in Mumbai, India.
